Reporting
CTNPT 032: The Camu Camu Pilot Study
Camu Camu effects on circulating LPS and systemic immune activation in ART-treated participants
Learn MoreReporting
Camu Camu effects on circulating LPS and systemic immune activation in ART-treated participants
Learn MoreOngoing
Terminated
Probiotic Visbiome for Inflammation and Translocation in HIV (PROOV IT I)
Learn MoreCompleted
Role of extended-released niacin on immune activation in HIV-infected patients treated with antiretroviral therapy: a proof-of-concept study
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.